| Factor 1 (Eigenvalue = 3.32, variance explained = 33.27%, α = 0.85 |
| 3/ Key characteristics of a reactive NST |
0.812 |
0.771 |
| 4/ Definition and attribution of variable decelerations |
0.805 |
0.669 |
| 1/ Range and determinants of FHR baseline |
0.778 |
0.793 |
| 4/ Range and determinants of FHR variability |
0.751 |
0.832 |
| Factor 2 (Eigenvalue = 2.41, variance explained = 24.12%, cumulative variance explained = 57.39%, α = 0.82 |
| 10/ Classification of CTG traces from compensatory to abnormal |
0.860 |
0.885 |
| 6/ Definition and management of severe bradycardia |
0.725 |
0.635 |
| 5/ Definition and attribution of late decelerations |
0.712 |
0.680 |
| Factor 3 (Eigenvalue = 1.56, variance explained = 15.6%, cumulative variance explained = 72.99%, α = 0.80 |
| 7/ Progressive hypoxia and CTG traces |
0.785 |
0.637 |
| 8/ Identification of risk for neurological defect and ph |
0.749 |
0.629 |
| 5/Apgar score, accelerations and risk of acidosis |
0.745 |
0.769 |
| NST: Non stress test, FHR: Fetal Heart Rate, CTG: Cardiotocography |
